| Literature DB >> 33789701 |
Shuang Leng1, Ru-San Tan1,2, Jiajun Guo3, Ping Chai4,5, Gangcheng Zhang6, Lynette Teo5,7, Wen Ruan1, Tee Joo Yeo4,5, Xiaodan Zhao1, John C Allen2, Ju Le Tan1,2, James W Yip4,5, Yucheng Chen8, Liang Zhong9,10.
Abstract
BACKGROUND: Parameters of myocardial deformation may provide improved insights into right ventricular (RV) dysfunction. We quantified RV longitudinal myocardial function using a fast, semi-automated method and investigated its diagnostic and prognostic values in patients with repaired tetralogy of Fallot (rTOF) and pulmonary arterial hypertension (PAH), who respectively exemplify patients with RV volume and pressure overload conditions.Entities:
Keywords: Cardiovascular magnetic resonance; Pressure overload; Right ventricular function; Strain; Volume overload
Year: 2021 PMID: 33789701 PMCID: PMC8015087 DOI: 10.1186/s12968-021-00724-5
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Top Semi-automatic tracking of tricuspid annular insertions and right ventricular (RV) epicardial apex, Bottom The strain of each wall (RV septal and free wall) was calculated using the presented strain formula. RV fast global longitudinal strain (FGLS) and peak strain rates (FGLSRs, FGLSRe, and FGLSRa) were extracted from the strain and strain rate curves
Demographic, clinical characteristics and fast RV strain data of study subjects
| Variables | Healthy Controls | rTOF | PAH |
|---|---|---|---|
| Age, years | 37 ± 15 | 31 ± 12* | 37 ± 15# |
| Gender, Male/Female | 16/59 | 39/36* | 16/59# |
| Body surface area, m2 | 1.6 ± 0.2 | 1.7 ± 0.2 | 1.5 ± 0.2*# |
| Diastolic blood pressure, mmHg | 74 ± 11 | 71 ± 9 | 71 ± 12 |
| Systolic blood pressure, mmHg | 126 ± 18 | 121 ± 16 | 112 ± 19*# |
| Heart rate, bpm | 76 ± 13 | 78 ± 15 | 85 ± 16*# |
| WHO class (> 1), n (%) | 0 (0 %) | 4 (5.3 %) | 69 (92 %)*# |
| CMR: left ventricle | |||
| LVEDVI, ml/m2 | 70 ± 11 | 73 ± 17 | 72 ± 30 |
| LVESVI, ml/m2 | 26 ± 7 | 30 ± 11* | 32 ± 17* |
| LVSVI, ml/m2 | 44 ± 6 | 43 ± 9 | 41 ± 16 |
| LVEF, % | 64 ± 6 | 59 ± 8* | 57 ± 10* |
| LV mass index, g/m2 | 40 ± 10 | 48 ± 12* | 54 ± 19*# |
| CMR: right ventricle | |||
| RVEDVI, ml/m2 | 73 ± 13 | 142 ± 30* | 122 ± 59*# |
| RVESVI, ml/m2 | 30 ± 10 | 77 ± 19* | 74 ± 46* |
| RVSVI, ml/m2 | 42 ± 7 | 65 ± 16* | 48 ± 23# |
| RVEF, % | 60 ± 7 | 46 ± 6* | 42 ± 14*# |
| RV GCS, % | 12.0 ± 4.2 | 15.4 ± 5.2* | 11.0 ± 5.3# |
| RV GLS, % | 29.6 ± 3.1 | 23.8 ± 3.0* | 20.4 ± 5.9*# |
| RV GLSRs, 1/s | 1.5 ± 0.3 | 1.1 ± 0.2* | 1.1 ± 0.4* |
| RV GLSRe, 1/s | 1.5 ± 0.4 | 1.4 ± 0.4 | 0.8 ± 0.4*# |
| RV GLSRa, 1/s | 1.0 ± 0.4 | 0.6 ± 0.3* | 1.0 ± 0.5# |
| RV fast GLS, % | 24.4 ± 3.0 | 19.3 ± 2.4* | 15.1 ± 4.9*# |
| RV fast GLSRs, 1/s | 1.2 ± 0.3 | 0.9 ± 0.2* | 0.9 ± 0.3*# |
| RV fast GLSRe, 1/s | 1.7 ± 0.4 | 1.4 ± 0.4* | 0.8 ± 0.4*# |
| RV fast GLSRa, 1/s | 1.0 ± 0.3 | 0.6 ± 0.2* | 0.8 ± 0.4*# |
Data are presented as mean ± SD or n (%)
CMR cardiovascular magnetic resonance, EDVI end-diastolic volume index, EF ejection fraction, ESVI end-systolic volume index, GLS global longitudinal strain, GLSRs peak global longitudinal strain rate during systole, GLSRe peak global longitudinal strain rate during early diastole, GLSRa peak global longitudinal strain rate during late diastole, LV left ventricular, PAH pulmonary arterial hypertension, rTOF repaired tetralogy of Fallot, RV right ventricular, SVI stroke volume index, WHO World Health Organization
*Significant difference compared to healthy controls; #Significant difference compared to rTOF
Demographic and clinical characteristics in rTOF with normal and subnormal exercise capacity
| Variables | Normal exercise capacity (n = 22) | Subnormal exercise capacity (n = 53) |
|
|---|---|---|---|
| Age, years | 29 ± 9 | 32 ± 13 | 0.243 |
| Gender, Male/Female | 12/10 | 27/26 | 0.805 |
| Body surface area, m2 | 1.8 ± 0.2 | 1.6 ± 0.2 | 0.012 |
| Diastolic blood pressure, mmHg | 71 ± 11 | 71 ± 9 | 0.809 |
| Systolic blood pressure, mmHg | 120 ± 14 | 121 ± 17 | 0.719 |
| Heart rate, bpm | 78 ± 12 | 78 ± 16 | 0.964 |
| Cardiopulmonary exercise testing | |||
| METs | 8.3 ± 1.6 | 6.3 ± 1.5 | < 0.001 |
| PVO2, ml/kg/min | 29.0 ± 5.7 | 22.1 ± 5.3 | < 0.001 |
| % predicted PVO2 | 96.7 ± 10.2 | 69.9 ± 10.5 | < 0.001 |
| CMR: right ventricle | |||
| RVEDVI, ml/m2 | 158 ± 24 | 135 ± 30 | 0.002 |
| RVESVI, ml/m2 | 87 ± 14 | 73 ± 19 | 0.002 |
| RVSVI, ml/m2 | 72 ± 15 | 62 ± 16 | 0.022 |
| RVEF, % | 45 ± 5 | 46 ± 6 | 0.512 |
Data are presented as mean ± SD
CMR cardiovascular magnetic resonance, EDVI end-diastolic volume index, EF ejection fraction, ESVI end-systolic volume index, METs metabolic equivalents, PVO2 peak oxygen consumption, RV right ventricular, SVI stroke volume index
Demographic and clinical characteristics in PAH with (PAH-C) and without (PAH-D) hemodynamic compensation
| Variables | PAH-C | PAH-D |
|
|---|---|---|---|
| Age, years | 36 ± 15 | 41 ± 14 | 0.246 |
| Gender, Male/Female | 9/46 | 7/13 | 0.081 |
| Body surface area, m2 | 1.5 ± 0.2 | 1.6 ± 0.3 | 0.074 |
| Diastolic blood pressure, mmHg | 69 ± 11 | 76 ± 15 | 0.026 |
| Systolic blood pressure, mmHg | 109 ± 17 | 118 ± 24 | 0.074 |
| Heart rate, bpm | 85 ± 16 | 87 ± 16 | 0.671 |
| WHO class (> 1), n (%) | 50 (91 %) | 19 (95 %) | 0.635 |
| 6MWD, m | 433 ± 86 | 380 ± 107 | 0.049 |
| Right heart catheterization | |||
| RA pressure, mmHg | 5 ± 2 | 16 ± 6 | < 0.001 |
| mPAP, mmHg | 53 ± 22 | 62 ± 22 | 0.137 |
| PCWP, mmHg | 9 ± 4 | 13 ± 4 | < 0.001 |
| PVR, Wood units | 11 ± 8 | 15 ± 11 | 0.146 |
| CMR: right ventricle | |||
| RVEDVI, ml/m2 | 120 ± 56 | 129 ± 68 | 0.584 |
| RVESVI, ml/m2 | 72 ± 44 | 81 ± 50 | 0.444 |
| RVSVI, ml/m2 | 48 ± 23 | 48 ± 26 | 0.910 |
| RVEF, % | 43 ± 13 | 40 ± 15 | 0.339 |
Data are presented as mean ± SD or n (%)
6MWD six-minute walking distance, CMR cardiovascular magnetic resonance, EDVI end-diastolic volume index, EF ejection fraction, ESVI end-systolic volume index, mPAP mean pulmonary artery pressure, PAH-C compensated pulmonary arterial hypertension, PAH-D decompensated pulmonary arterial hypertension, PCWP pulmonary capillary wedge pressure, PVR pulmonary vascular resistance, RA right atrial, RV right ventricular, SVI stroke volume index, WHO World Health Organization
Clinical characteristics in PAH with low, intermediate and high risks
| Variables | Low risk | Intermediate risk | High risk |
|---|---|---|---|
| WHO class (> 1), n (%) | 25 (89 %) | 31 (91 %) | 13 (100 %) |
| 6MWD, m | 461 ± 68 | 403 ± 97* | 344 ± 103* |
| NT-proBNP, pg/ml | 140 (60, 308) | 605 (223, 1820)* | 3475 (1678, 7344)*# |
| Maximal RA area, cm2 | 17 ± 6 | 24 ± 7* | 42 ± 17*# |
| RA pressure, mmHg | 5.8 ± 2.8 | 6.1 ± 3.6 | 16.8 ± 8.4*# |
| Cardiac index, l/min/m2 | 3.6 ± 2.7 | 2.5 ± 1.0* | 2.1 ± 0.6* |
| RVEF, % | 50 ± 10 | 39 ± 13* | 32 ± 11* |
Data are presented as mean ± SD, median (IQR) or n (%)
6MWD six-minute walking distance, EF ejection fraction, NT-proBNP N-terminal pro-brain natriuretic peptide, RA right atrial, RV right ventricular, WHO World Health Organization
*Significant difference compared to low risk; #significant difference compared to intermediate risk
Fig. 2Correlation and Bland-Altman plots (1st row) between RV fast GLS and RV GLS, (2nd row) between RV fast GLSRs and RV GLSRs, (3rd row) between RV fast GLSRe and RV GLSRe, and (4th row) between RV fast GLSRa and RV GLSRa. In correlation plots, solid line and dash lines denote Passing-Bablok non-parametric regression line and 95 % confidence interval, respectively
Intra- and inter-observer reproducibility for fast global longitudinal strain and strain rate measurements at different field strengths
| Variables | Intra-observer CV, % | Inter-observer CV, % | ||
|---|---|---|---|---|
| 1.5 T (n = 10) | 3 T (n = 10) | 1.5 T (n = 10) | 3 T (n = 10) | |
| RV fast GLS, % | 3.1 | 2.9 | 4.2 | 3.7 |
| RV fast GLSRs, 1/s | 6.6 | 6.1 | 7.2 | 7.3 |
| RV fast GLSRe, 1/s | 6.5 | 6.8 | 8.6 | 8.4 |
| RV fast GLSRa, 1/s | 7.9 | 7.2 | 9.5 | 10.1 |
CV coefficient of variation, GLS global longitudinal strain, GLSRs peak global longitudinal strain rate during systole, GLSRe peak global longitudinal strain rate during early diastole, GLSRa peak global longitudinal strain rate during late diastole, RV right ventricular
Fig. 3Correlation between right ventricular (RV) fast global longitudinal strain (FGLS) and RV ejection fraction (RVEF) (r = 0.71) in the entire subject cohort
Fig. 4Right ventricular (RV) fast global longitudinal strain (FGLS) and strain rates (FGLSRs, FGLSRe, and FGLSRa) in a rTOF patients with normal and subnormal exercise capacity, b compensated pulmonary arterial hypertension (PAH-C) and decompensated pulmonary arterial hypertension (PAH-D), c PAH with low, intermediate and high risks of clinical worsening. *Significant difference compared to those with normal exercise capacity/PAH-C/low risk; #Significant difference compared to those with intermediate risk
Fig. 5Linear relationship of right ventricular (RV) fast global longitudinal strain (FGLS) to a Percent of predicted peak oxygen consumption (% Predicted PVO2) (r = 0.58) and b peak oxygen consumption (PVO2) (r = 0.41) in rTOF patients
Fig. 6Utility of right ventricular (RV) fast global longitudinal strain (FGLS), conventional RV GLS and RV ejection fraction (RVEF) to discriminate a subnormal exercise capacity in rTOF patients, b RV decompensation in PAH patients, c intermediate and high risks of clinical worsening in PAH patients
Intra- and inter-observer reproducibility for RV strain and strain rate measurements derived by fast and conventional feature tracking approaches
| Method | RV strain /strain rate | Intra-observer (n = 30) | Inter-observer (n = 30) | ||
|---|---|---|---|---|---|
| Bias (limits of agreement) | CV (%) | Bias (limits of agreement) | CV (%) | ||
| Fast strain approach | Fast GLS, % | − 0.1 (− 1.6, 1.4) | 2.9 | − 0.3 (− 2.3, 1.8) | 3.9 |
| Fast GLSRs, 1/s | − 0.04 (− 0.20, 0.12) | 6.3 | − 0.03 (− 0.22, 0.17) | 7.0 | |
| Fast GLSRe, 1/s | − 0.02 (− 0.23, 0.20) | 6.5 | − 0.03 (− 0.30, 0.23) | 8.1 | |
| Fast GLSRa, 1/s | − 0.03 (− 0.21, 0.15) | 7.5 | − 0.03 (− 0.27, 0.20) | 9.6 | |
| Feature tracking approach | GLS, % | − 0.2 (− 4.3, 3.9) | 6.0 | − 0.1 (− 5.3, 5.1) | 7.5 |
| GLSRs, 1/s | − 0.02 (− 0.33, 0.29) | 9.3 | − 0.02 (− 0.36, 0.32) | 10.1 | |
| GLSRe, 1/s | 0.10 (− 0.23, 0.43) | 12.1 | 0.04 (− 0.40, 0.47) | 13.3 | |
| GLSRa, 1/s | − 0.06 (− 0.37, 0.25) | 12.9 | − 0.04 (− 0.40, 0.32) | 14.4 | |
CV coefficient of variation, GLS global longitudinal strain, GLSRs peak global longitudinal strain rate during systole, GLSRe peak global longitudinal strain rate during early diastole, GLSRa peak global longitudinal strain rate during late diastole, RV right ventricular